参与两年一度乳腺X线筛查女性中双侧筛查检出癌与双侧间期癌的肿瘤特征
研究纳入2005年1月至2015年1月荷兰南部468720次两年一度筛查乳腺X线,比较双侧筛查检出癌与双侧间期癌的肿瘤特征。双侧间期癌指数癌T2+比例高于双侧筛查检出癌(66.7% vs 39.7%,P=0.03),淋巴结、受体状态及最终手术方式可比。
要点
- 双侧间期癌指数癌T2+比例66.7%,高于双侧筛查检出癌的39.7%(P=0.03)。
- 两组指数癌在淋巴结状态、受体状态及最终手术方式上表现相似。
- 双侧筛查检出癌中,对侧癌T1比例高于指数癌(88.9% vs 60.3%,P=0.001)。
核心结论
- 双侧筛查检出癌与双侧间期癌的指数癌在肿瘤大小上存在显著差异,而淋巴结状态、受体状态和最终手术治疗相当;双侧筛查检出癌中指数癌分期显著更高,且更常为浸润性导管亚型。
研究设计与样本
- 研究纳入2005年1月至2015年1月荷兰南部接受两年一度筛查乳腺X线的女性共468720次筛查影像,收集召回女性及间期乳腺癌患者的乳腺影像报告、活检结果和手术报告,同步双侧乳腺癌中以肿瘤分期最高者为指数癌,采用Fisher精确检验和卡方检验比较两组数据。
诊断标准与关键数值
- 同步双侧癌在筛查检出癌中占2.2%(64/2947),在间期癌中占3.2%(24/753)(P=0.1)。
- 双侧间期癌指数癌T2+比例为16/24(66.7%),双侧筛查检出癌为23/58(39.7%)(P=0.03)。
- 双侧筛查检出癌中指数癌T1比例为35/64(60.3%),对侧癌为40/64(88.9%)(P=0.001)。
- 双侧间期癌中指数癌T1比例为8/24(33.3%),对侧癌为18/24(85.7%)(P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Unilateral interval breast cancers show less favourable prognostic features than unilateral screen-detected cancers, but data on tumour characteristics of bilateral interval cancers in a systematically screened population are sparse. Therefore, we compared tumour characteristics of bilateral interval cancers with those of bilateral screen-detected cancers.
METHODS: We included all 468,720 screening mammograms of women who underwent biennial screening mammography in the South of the Netherlands between January 2005 and January 2015. We collected breast imaging reports, biopsy results and surgical reports of all recalled women and of all women who presented with interval breast cancer. In women with synchronous bilateral breast cancer, the tumour with the highest tumour stage was defined as the index cancer. For comparison of data between both groups Fisher exact test and Chi-square test were used.
RESULTS: Synchronous bilateral cancer was diagnosed in 2.2% of screen-detected cancers (64/2947) and in 3.2% of interval cancers (24/753) (P = 0.1). Index tumours of bilateral screen-detected cancers and interval cancers showed similar characteristics, except for a larger proportion of T-stage 2 or worse (T2+) cancers among interval cancers (16/24 (66.7%) versus 23/58 (39.7%) (P = 0.03). Index cancers, compared to contralateral cancers, were less frequently stage T1 in both bilateral screen-detected cancers and bilateral interval cancers (35/64 (60.3%) versus 40/64 (88.9%) (P = 0.001) and 8/24 (33.3%) versus 18/24 (85.7%) (P < 0.001), respectively). In bilateral screen-detected cancers, contralateral cancers were more often stage 1a-c (P < 0.001) compared to index cancers. In bilateral index cancers, index cancers were more often of the lobular subtype (P < 0.001).
CONCLUSION: Index cancers of bilateral screen-detected cancers and bilateral interval cancers show significant differences in tumour size, whereas nodal status, receptor status and final surgical treatment are comparable. In bilateral screen-detected cancer, index cancers had a significantly higher tumour stage. In bilateral screen-detected cancer, index cancers were more often the ductal invasive subtype compared to contralateral cancers.
引用
- van Bommel R, Lameijer JRC, Voogd AC, et al. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography. Eur J Radiol. 2018. PMID: 30396659. doi:10.1016/j.ejrad.2018.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。